Lista de obras - Kathryn E. Foulds - Dominio Público Uruguay

Adjuvant Dependent Mucosal V2 Responses and RAS Activation in Vaccine Induced Protection from SIVmac251 Acquisition.

artículo científico publicado en 2014

Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

artículo científico publicado en 2016

Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization

artículo científico publicado en 2019

Blocking α4β7 integrin binding to SIV does not improve virologic control

artículo científico publicado en 2019

Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition

artículo científico publicado en 2016

Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection

artículo científico publicado en 2015

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

artículo científico publicado en 2014

Clonal competition inhibits the proliferation and differentiation of adoptively transferred TCR transgenic CD4 T cells in response to infection

artículo científico publicado en 2006

Conservation of molecular and cellular phenotypes of invariant NKT cells between humans and non-human primates

artículo científico publicado en 2019

Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC"

scientific article published on 15 October 2019

Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses

artículo científico publicado en 2002

DNA vaccination before conception protects Zika virus-exposed pregnant macaques against prolonged viremia and improves fetal outcomes

artículo científico publicado en 2019

Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality

artículo científico publicado en 2020

Early antibody therapy can induce long-lasting immunity to SHIV

artículo científico publicado en 2017

Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1

artículo científico publicado en 2018

Erratum: Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

artículo científico publicado en 2016

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

artículo científico publicado en 2020

Expression of CD40L by the ALVAC-Simian Immunodeficiency Virus Vector Abrogates T Cell Responses in Macaques

artículo científico publicado en 2020

Gene-Based Vaccination with a Mismatched Envelope Protects against Simian Immunodeficiency Virus Infection in Nonhuman Primates ⬇️

artículo científico publicado el 16 de mayo de 2012

HIV vaccine candidate activation of hypoxia and the inflammasome in CD14 monocytes is associated with a decreased risk of SIV acquisition

article

HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Speci

artículo científico publicado en 2017

Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates

artículo científico publicado en 2015

Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs

artículo científico publicado en 2015

IFN-gamma mediates the death of Th1 cells in a paracrine manner.

artículo científico publicado en 2008

IL-10 is required for optimal CD8 T cell memory following Listeria monocytogenes infection.

artículo científico publicado en 2006

Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature

artículo científico publicado en 2020

Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

artículo científico publicado en 2021

Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV.

artículo científico publicado en 2013

Monocytes Acquire the Ability to Prime Tissue-Resident T Cells via IL-10-Mediated TGF-β Release

artículo científico publicado en 2019

Myeloid Cell Crosstalk Regulates the Efficacy of the DNA/ALVAC/gp120 HIV Vaccine Candidate

article

Nonsecreted bacterial proteins induce recall CD8 T cell responses but do not serve as protective antigens.

artículo científico publicado en 2002

OMIP-052: An 18-Color Panel for Measuring Th1, Th2, Th17, and Tfh Responses in Rhesus Macaques

scientific article published on 25 January 2019

OMIP‐005: Quality and phenotype of antigen‐responsive rhesus macaque T cells ⬇️

artículo científico publicado el 21 de marzo de 2012

Optimization and qualification of an 8-color intracellular cytokine staining assay for quantifying T cell responses in rhesus macaques for pre-clinical vaccine studies

artículo científico publicado en 2012

P13-07 LB. A human blocking antibody to CCR5 partially protects against lentiviral infection in non-human primates

artículo científico publicado en 2009

Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens

artículo científico publicado en 2016

Priming with a potent HIV-1 DNA vaccine frames the quality of immune responses prior to a poxvirus and protein boost

article

Proceedings of the Frontiers of Retrovirology Conference 2016.

artículo científico publicado en 2016

Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation

artículo científico publicado en 2017

RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues

artículo científico publicado en 2012

Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes

article

Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector

artículo científico publicado en 2019

Replication-competent NYVAC-KC yields improved immunogenicity to HIV-1 antigens in rhesus macaques, compared to non-replicating NYVAC

article

Safety and tolerability of a live oral Salmonella typhimurium vaccine candidate in SIV-infected nonhuman primates

artículo científico publicado en 2013

Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4

article published in the Proceedings of the National Academy of Sciences of the United States of America

Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses

artículo científico publicado en 2017

TNF is important for pathogen control and limits brain damage in murine cerebral listeriosis

artículo científico publicado en 2006

Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques

artículo científico publicado en 2016

Th1 memory: implications for vaccine development

artículo científico publicado en 2006

mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates

scholarly article by Kizzmekia Corbett et al published 20 August 2021 in Nature Immunology

Lista de obras de Kathryn E. Foulds

Adjuvant Dependent Mucosal V2 Responses and RAS Activation in Vaccine Induced Protection from SIVmac251 Acquisition.

Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization

Blocking α4β7 integrin binding to SIV does not improve virologic control

Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition

Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

Clonal competition inhibits the proliferation and differentiation of adoptively transferred TCR transgenic CD4 T cells in response to infection

Conservation of molecular and cellular phenotypes of invariant NKT cells between humans and non-human primates

Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC"

Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses

DNA vaccination before conception protects Zika virus-exposed pregnant macaques against prolonged viremia and improves fetal outcomes

Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality

Early antibody therapy can induce long-lasting immunity to SHIV

Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1

Erratum: Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

Expression of CD40L by the ALVAC-Simian Immunodeficiency Virus Vector Abrogates T Cell Responses in Macaques

Gene-Based Vaccination with a Mismatched Envelope Protects against Simian Immunodeficiency Virus Infection in Nonhuman Primates ⬇️

HIV vaccine candidate activation of hypoxia and the inflammasome in CD14 monocytes is associated with a decreased risk of SIV acquisition

HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Speci

Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates

Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs

IFN-gamma mediates the death of Th1 cells in a paracrine manner.

IL-10 is required for optimal CD8 T cell memory following Listeria monocytogenes infection.

Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature

Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV.

Monocytes Acquire the Ability to Prime Tissue-Resident T Cells via IL-10-Mediated TGF-β Release

Myeloid Cell Crosstalk Regulates the Efficacy of the DNA/ALVAC/gp120 HIV Vaccine Candidate

Nonsecreted bacterial proteins induce recall CD8 T cell responses but do not serve as protective antigens.

OMIP-052: An 18-Color Panel for Measuring Th1, Th2, Th17, and Tfh Responses in Rhesus Macaques

OMIP‐005: Quality and phenotype of antigen‐responsive rhesus macaque T cells ⬇️

Optimization and qualification of an 8-color intracellular cytokine staining assay for quantifying T cell responses in rhesus macaques for pre-clinical vaccine studies

P13-07 LB. A human blocking antibody to CCR5 partially protects against lentiviral infection in non-human primates

Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens

Priming with a potent HIV-1 DNA vaccine frames the quality of immune responses prior to a poxvirus and protein boost

Proceedings of the Frontiers of Retrovirology Conference 2016.

Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation

RV144-like trial in macaques using ALVAC-SIV & gp120 induces innate immunity and increases the frequency of NK22 & NKG2A+ cells in mucosal tissues

Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes

Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector

Replication-competent NYVAC-KC yields improved immunogenicity to HIV-1 antigens in rhesus macaques, compared to non-replicating NYVAC

Safety and tolerability of a live oral Salmonella typhimurium vaccine candidate in SIV-infected nonhuman primates

Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4

Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses

TNF is important for pathogen control and limits brain damage in murine cerebral listeriosis

Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques

Th1 memory: implications for vaccine development

mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates